Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis

Ashwin S. Dharmadhikari, Mohan Kabadi, Bob Gerety, Anthony J. Hickey, P. Bernard Fourie, Edward Nardell
  • Antimicrobial Agents and Chemotherapy, March 2013, ASM Journals
  • DOI: 10.1128/aac.02346-12

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr P Bernard Fourie

In partnership with: